The Oncology Institute, Inc. TOI Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s other income, net (note 6)?
- The Oncology Institute, Inc. (TOI) reported other income, net (note 6) of $791K in Q1 2026.
- How has The Oncology Institute, Inc.'s other income, net (note 6) changed year-over-year?
- The Oncology Institute, Inc.'s other income, net (note 6) increased by 205.2% year-over-year, from -$752K to $791K.
- What is the long-term trend for The Oncology Institute, Inc.'s other income, net (note 6)?
- Over 3 years (2021 to 2024), The Oncology Institute, Inc.'s other income, net (note 6) has grown at a -31.3% compound annual growth rate (CAGR), from $1.13M to -$365K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.